Tammy Romo Sells 4,922 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 4,922 shares of the business’s stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $264.15, for a total value of $1,300,146.30. Following the sale, the director owned 30,784 shares of the company’s stock, valued at approximately $8,131,593.60. The trade was a 13.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Tammy Romo also recently made the following trade(s):

• On Friday, August 7th, Tammy Romo sold 2,500 shares of Tenet Healthcare stock. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00.

Tenet Healthcare Trading Down 0.7%

NYSE THC traded down $1.80 during trading hours on Monday, hitting $260.33. The company’s stock had a trading volume of 889,058 shares, compared to its average volume of 1,475,405. The stock has a fifty day moving average of $202.01 and a 200 day moving average of $201.90. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. The firm has a market capitalization of $20.96 billion, a P/E ratio of 10.04, a PEG ratio of 1.00 and a beta of 1.23. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $265.32.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, topping analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a return on equity of 26.76% and a net margin of 10.27%.The business had revenue of $6.04 billion during the quarter, compared to analysts’ expectations of $5.43 billion. During the same period in the previous year, the firm earned $4.02 earnings per share. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. Equities research analysts forecast that Tenet Healthcare Corporation will post 21.09 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on THC shares. UBS Group boosted their price objective on shares of Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. Truist Financial upped their price objective on shares of Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research report on Tuesday, July 28th. Guggenheim lifted their target price on Tenet Healthcare from $242.00 to $283.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Finally, Barclays increased their price target on Tenet Healthcare from $240.00 to $271.00 and gave the stock an “overweight” rating in a report on Friday, July 24th. Seventeen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $272.25.

Institutional Investors Weigh In On Tenet Healthcare

Several large investors have recently made changes to their positions in THC. NewEdge Advisors LLC increased its holdings in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after purchasing an additional 166 shares in the last quarter. Jones Financial Companies Lllp lifted its holdings in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC bought a new position in shares of Tenet Healthcare during the second quarter worth about $290,000. Quantbot Technologies LP bought a new stake in Tenet Healthcare in the 2nd quarter valued at approximately $65,000. Finally, Amundi boosted its position in Tenet Healthcare by 4,207.8% during the 2nd quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after acquiring an additional 26,383 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.